Cellectis (France) Executives

Cellectis Management Team Effectiveness

The company has return on total asset (ROA) of (0.0447) % which means that it has lost $0.0447 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.3075) %, meaning that it generated substantial loss on money invested by shareholders. Cellectis' management efficiency ratios could be used to measure how well Cellectis manages its routine affairs as well as how well it operates its assets and liabilities. As of 02/09/2026, Return On Tangible Assets is likely to drop to -0.09. In addition to that, Return On Capital Employed is likely to drop to -0.26. At this time, Cellectis' Total Current Liabilities is relatively stable compared to the past year. As of 02/09/2026, Non Current Liabilities Total is likely to grow to about 104.1 M, while Liabilities And Stockholders Equity is likely to drop slightly above 279.2 M. As of 02/09/2026, Common Stock Shares Outstanding is likely to grow to about 108.5 M, while Net Loss is likely to drop (34.7 M). Cellectis holds a total of 72.33 Million outstanding shares. Cellectis retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it. As of 02/09/2026, Dividend Paid And Capex Coverage Ratio is likely to grow to 7.22. As of 02/09/2026, Common Stock Shares Outstanding is likely to grow to about 108.5 M, while Net Loss is likely to drop (34.7 M).

Cellectis Workforce Comparison

Cellectis Profit Margins

The company has Profit Margin (PM) of (0.43) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.22 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.22.

Cellectis Benchmark Summation

Cellectis Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as Cellectis often depends on how effective the management is. Cellectis management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Cellectis management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Cellectis management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

When running Cellectis' price analysis, check to measure Cellectis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellectis is operating at the current time. Most of Cellectis' value examination focuses on studying past and present price action to predict the probability of Cellectis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellectis' price. Additionally, you may evaluate how the addition of Cellectis to your portfolios can decrease your overall portfolio volatility.